在晚期宫癌中对免疫挑战的反应的时空空间免疫决定因素
Chunyan Lan1, Peidong Zhang2, Jing Zhao1
1Sun Yat-sen University Cancer Center Guangzhou China.
Cancer discovery
|January 9, 2026
概括
使用齐姆贝利利马布和伦瓦提尼布的免疫再挑战对在初始免疫检查点抑制剂 (ICI) 治疗后复发的晚期宫癌患者有希望. 这种方法可以恢复抗瘤免疫力,并为耐火性疾病提供新的治疗选择.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 免疫检查点抑制剂 (ICI) 提供持久的反应,但复发在晚期癌症中很常见.
- 在进展后重新使用ICI治疗的疗效尚未得到充分证实.
- 晚期宫癌患者在疾病进展后经常面临有限的治疗选择.
研究的目的:
- 评估先前ICI治疗期间或之后进展的晚期宫癌患者使用齐姆贝利利马布和伦瓦提尼布进行免疫再挑战的疗效.
- 用单细胞多组学来研究与免疫再挑战相关的免疫变化.
- 在这个患者群体中确定与临床益处相关的生物标志物.
主要方法:
- 一个多中心,单臂,第二期临床试验 (NCT05824468) 招募了30名患有晚期宫癌的患者.
- 患者接受了辛贝利利马布和伦瓦提尼布的联合治疗方案,作为免疫再挑战.
- 单细胞多组体分析是在连续的瘤活检和血液样本上进行的.
主要成果:
- 免疫再挑战诱导了响应者更有细胞毒性的CD8+T细胞表型.
- 没有反应的人在血液中表现出NK类的CD8+T和原始体耗尽的CD8+T细胞表型.
- 受访者在治疗后的瘤中显示了效能记忆CD8+T细胞的增加和耗尽CD8+T细胞的减少.
- 一个CD45+CD3+Lyz+二细胞群与临床益处相关.
结论:
- 用齐姆贝利利马布和伦瓦提尼布进行免疫再挑战是先进的宫癌患者的潜在有效治疗策略,这些患者在先前的ICI治疗中进展.
- 了解对再挑战的免疫反应可以为未来的治疗策略提供信息.
- 已识别的二细胞群可以作为治疗反应的预测生物标志物.
更多相关视频
10:13Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
9.5K
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
10.2K
相关概念视频
Cells of the Adaptive Immune Response
8.4K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.4K
Cell-mediated Immune Responses
83.4K
Overview
83.4K
Immunological Memory
15.0K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
15.0K
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
T Cell Activation and Clonal Selection
14.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.7K
